282 related articles for article (PubMed ID: 18570924)
1. The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of pancreatic fibrosis in an experimental model of severe hyperstimulation and obstruction pancreatitis.
Karatas A; Paksoy M; Erzin Y; Carkman S; Gonenc M; Ayan F; Aydogan F; Uzun H; Durak H
J Surg Res; 2008 Jul; 148(1):7-12. PubMed ID: 18570924
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
[TBL] [Abstract][Full Text] [Related]
3. The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of esophageal strictures related to caustic injury.
Ozçelik MF; Pekmezci S; Saribeyoğlu K; Unal E; Gümüştaş K; Doğusoy G
Am J Surg; 2004 Feb; 187(2):257-60. PubMed ID: 14769315
[TBL] [Abstract][Full Text] [Related]
4. [Effect of emodin on pancreatic fibrosis: experiment with rats].
Wang CH; Gao ZQ; Ye B; Xie CG; Qian KD; Cai JT; Du Q
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2552-5. PubMed ID: 17198564
[TBL] [Abstract][Full Text] [Related]
5. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
Benchetrit S; Yarkoni S; Rathaus M; Pines M; Rashid G; Bernheim J; Bernheim J
Isr Med Assoc J; 2007 Jan; 9(1):30-4. PubMed ID: 17274353
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic stellate cell activation and MMP production in experimental pancreatic fibrosis.
Yokota T; Denham W; Murayama K; Pelham C; Joehl R; Bell RH
J Surg Res; 2002 May; 104(2):106-11. PubMed ID: 12020128
[TBL] [Abstract][Full Text] [Related]
7. Decreased type IV collagenase activity in experimental pancreatic fibrosis.
Ng EK; Barent BL; Smith GS; Joehl RJ; Murayama KM
J Surg Res; 2001 Mar; 96(1):6-9. PubMed ID: 11180989
[TBL] [Abstract][Full Text] [Related]
8. Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis.
Hackert T; Werner J; Gebhard MM; Klar E
Surgery; 2004 Feb; 135(2):131-8. PubMed ID: 14739847
[TBL] [Abstract][Full Text] [Related]
9. [The effect of intraperitoneally administered necrolytic enzymes on the course of experimental acute pancreatitis].
Madej B; Maciejewski R; Anasiewicz A; Radzikowska E
Wiad Lek; 1997; 50 Suppl 1 Pt 2():101-7. PubMed ID: 9424854
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of topically applied halofuginone in management of subglottic stenosis in rats.
Ertuğrul EE; Cekin IE; Cincik H; Doğru S; Güngör A
Otolaryngol Head Neck Surg; 2009 May; 140(5):720-3. PubMed ID: 19393418
[TBL] [Abstract][Full Text] [Related]
11. Melatonin treatment is beneficial in pancreatic repair process after experimental acute pancreatitis.
Sidhu S; Pandhi P; Malhotra S; Vaiphei K; Khanduja KL
Eur J Pharmacol; 2010 Feb; 628(1-3):282-9. PubMed ID: 19958759
[TBL] [Abstract][Full Text] [Related]
12. Halofuginone inhibits collagen deposition in fibrous capsules around implants.
Olbrich KC; Meade R; Bruno W; Heller L; Klitzman B; Levin LS
Ann Plast Surg; 2005 Mar; 54(3):293-6;discussion 296. PubMed ID: 15725837
[TBL] [Abstract][Full Text] [Related]
13. The effects of the Pringle maneuver on the pancreas: can octreotide be protective?
Unalp OV; Aydin U; Yazici P; Nart D; Yenisey C; Kavak T; Zeytunlu M; Coker A
JOP; 2009 May; 10(3):284-91. PubMed ID: 19454821
[TBL] [Abstract][Full Text] [Related]
14. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
Bruck R; Genina O; Aeed H; Alexiev R; Nagler A; Avni Y; Pines M
Hepatology; 2001 Feb; 33(2):379-86. PubMed ID: 11172339
[TBL] [Abstract][Full Text] [Related]
15. Halofuginone can worsen liver fibrosis in bile duct obstructed rats.
Van de Casteele M; Roskams T; Van der Elst I; van Pelt JF; Fevery J; Nevens F
Liver Int; 2004 Oct; 24(5):502-9. PubMed ID: 15482349
[TBL] [Abstract][Full Text] [Related]
16. Effects of R-102444 and its active metabolite R-96544, selective 5-HT2A receptor antagonists, on experimental acute and chronic pancreatitis: Additional evidence for possible involvement of 5-HT2A receptors in the development of experimental pancreatitis.
Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Fukushige J; Tani Y; Asai F
Eur J Pharmacol; 2005 Oct; 521(1-3):156-63. PubMed ID: 16183055
[TBL] [Abstract][Full Text] [Related]
17. Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.
Turgeman T; Hagai Y; Huebner K; Jassal DS; Anderson JE; Genin O; Nagler A; Halevy O; Pines M
Neuromuscul Disord; 2008 Nov; 18(11):857-68. PubMed ID: 18672370
[TBL] [Abstract][Full Text] [Related]
18. [Effects of N-acetylcysteine on mRNA expression of monocyte chemotactic protein and macrophage inflammatory protein 2 in acute necrotizing pancreatitis: experiment with rats].
Xu CF; Wu AR; Shen YZ
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):711-5. PubMed ID: 18642776
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel model of pancreatic fibrosis and acinar atrophy.
Murayama KM; Barent BL; Gruber M; Brooks A; Eliason S; Brunt EM; Smith GS
J Gastrointest Surg; 1999; 3(4):418-25. PubMed ID: 10482695
[TBL] [Abstract][Full Text] [Related]
20. The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model.
Nagler A; Gofrit O; Ohana M; Pode D; Genina O; Pines M
J Urol; 2000 Nov; 164(5):1776-80. PubMed ID: 11025768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
